These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8709448)

  • 21. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
    Catalona WJ; Smith DS; Wolfert RL; Wang TJ; Rittenhouse HG; Ratliff TL; Nadler RB
    JAMA; 1995 Oct; 274(15):1214-20. PubMed ID: 7563511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign.
    Cheli CD; Levine RL; Cambetas DR; Kolker JD; Roberts SB
    Urology; 2002 Oct; 60(4 Suppl 1):53-9. PubMed ID: 12384164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma.
    Dalkin BL; Ahmann FR; Kopp JB
    J Urol; 1993 Dec; 150(6):1837-9. PubMed ID: 7693980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinoma.
    Dalkin BL; Ahmann FR; Kopp JB; Catalona WJ; Ratliff TL; Hudson MA; Richie JP; Scardino PT; Flanigan RC; Dekernion JB
    Br J Urol; 1995 Sep; 76(3):346-50. PubMed ID: 7551844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of polyclonal serum prostate specific antigen levels in screening for prostate cancer: a comparison with corresponding monoclonal values.
    Terris MK; Stamey TA
    Br J Urol; 1994 Jan; 73(1):61-4. PubMed ID: 7507783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity.
    Ku JH; Ahn JO; Lee CH; Lee NK; Park YH; Byun SS; Kwak C; Lee SE
    Urology; 2002 Sep; 60(3):475-9. PubMed ID: 12350489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.
    Luderer AA; Chen YT; Soriano TF; Kramp WJ; Carlson G; Cuny C; Sharp T; Smith W; Petteway J; Brawer MK
    Urology; 1995 Aug; 46(2):187-94. PubMed ID: 7542820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate specific antigen as a predictor of an abnormal digital rectal examination.
    Lui PD; Terris MK; Haney DJ; Constantinou CE; Stamey TA
    Br J Urol; 1994 Sep; 74(3):337-40. PubMed ID: 7524998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
    Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
    Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population.
    He D; Wang M; Chen X; Gao Z; He H; Zhau HE; Wang W; Chung LW; Nan X
    Urology; 2004 Apr; 63(4):722-6. PubMed ID: 15072888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older.
    Oesterling JE; Jacobsen SJ; Cooner WH
    J Urol; 1995 Apr; 153(4):1160-3. PubMed ID: 7532725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mL.
    Berger AP; Cheli C; Levine R; Klocker H; Bartsch G; Horninger W
    Urology; 2003 Nov; 62(5):840-4. PubMed ID: 14624905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients.
    Battikhi MN
    Prostate Cancer Prostatic Dis; 2003; 6(3):256-60. PubMed ID: 12970732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.
    Carter HB; Epstein JI; Chan DW; Fozard JL; Pearson JD
    JAMA; 1997 May; 277(18):1456-60. PubMed ID: 9145718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of reference values for total PSA, F/T and PSAD according to prostatic volume in japanese prostate cancer patients with slightly elevated serum PSA levels.
    Kuriyama M; Uno H; Watanabe H; Yamanaka H; Saito Y; Shida K
    Jpn J Clin Oncol; 1999 Dec; 29(12):617-22. PubMed ID: 10721944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening.
    Reissigl A; Klocker H; Pointner J; Fink K; Horninger W; Ennemoser O; Strasser H; Colleselli K; Höltl L; Bartsch G
    Urology; 1996 Dec; 48(6A Suppl):62-6. PubMed ID: 8973702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
    Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
    Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostatic specific antigen (PA) in mass screening for prostate cancer].
    Ito K; Ohtake N; Hatori M; Mashimo T; Jimbo S; Tomaru Y; Makino T; Yajima H; Imai K; Yamanaka H
    Hinyokika Kiyo; 1992 Nov; 38(11):1225-9. PubMed ID: 1283053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.